financetom
Business
financetom
/
Business
/
BRIEF-BKV Announces Acquisition of Control Position in BKV-BPP Power Joint Venture to Accelerate Growth Strategy
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BRIEF-BKV Announces Acquisition of Control Position in BKV-BPP Power Joint Venture to Accelerate Growth Strategy
Oct 29, 2025 7:42 AM

Oct 29 (Reuters) - BKV Corp ( BKV ):

* BKV ANNOUNCES ACQUISITION OF CONTROL POSITION IN BKV-BPP

POWER

JOINT VENTURE TO ACCELERATE GROWTH STRATEGY

* BKV CORP ( BKV ) - TO BUY 75% INTEREST IN BKV-BPP POWER

* BKV CORP ( BKV ) - TO PAY $376 MILLION LESS 25% OF NET

INDEBTEDNESS

* BKV CORP ( BKV ) - CONSIDERATION PAID 50% IN CASH AND 50% IN BKV

STOCK

Source text:

Further company coverage:

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
China's Satellite Chemical pauses ethylene project amid US trade tensions, sources say
China's Satellite Chemical pauses ethylene project amid US trade tensions, sources say
Oct 24, 2025
* Satellite Chemical is China's biggest importer of US ethane * Project paused amid trade tensions, lack of government and regulatory approvals * Ethane cracker is part of multibillion-dollar expansion plan By Trixie Yap and Chen Aizhu SINGAPORE, Oct 24 (Reuters) - Satellite Chemical , China's largest importer of U.S. ethane, has paused plans to build its third ethylene unit...
Orchid Island Capital Q3 Net Income Increases
Orchid Island Capital Q3 Net Income Increases
Oct 24, 2025
03:29 AM EDT, 10/24/2025 (MT Newswires) -- Orchid Island Capital ( ORC ) reported Q3 net income Thursday of $0.53 per diluted share, up from $0.24 a year earlier. Two analysts polled by FactSet expected $0.22. Net interest income for the quarter ended Sept. 30 was $26.9 million, up from $340,000 a year earlier. ...
Renalys Pharma to be Acquired by Chugai Pharmaceutical
Renalys Pharma to be Acquired by Chugai Pharmaceutical
Oct 24, 2025
TOKYO, Oct. 24, 2025  /PRNewswire/ -- Renalys Pharma, Inc. and Chugai Pharmaceutical Co., Ltd. today announced a definitive stock purchase agreement, under which Chugai will acquire Renalys (the Transaction).  Renalys is advancing sparsentan in Japan; the medicine was initially developed by Travere Therapeutics, Inc. (Travere) and is approved in the United States and Europe for the treatment of IgA nephropathy....
Greece names Chevron, Helleniq Energy consortium as preferred bidder for offshore gas search
Greece names Chevron, Helleniq Energy consortium as preferred bidder for offshore gas search
Oct 24, 2025
ATHENS (Reuters) -Greece has named a consortium of U.S. oil major Chevron ( CVX ) and Helleniq Energy, the country's biggest oil refiner, as preferred bidder for gas exploration in southern offshore blocks, the Greek energy ministry said on Friday. The move comes after Chevron ( CVX ) and Helleniq submitted a joint bid in a Greek tender this year...
Copyright 2023-2026 - www.financetom.com All Rights Reserved